Jonathan D. Lippiat

Jonathan D. Lippiat

Auto-generated profile, based on publicly available information

Jonathan D. Lippiat

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
AHAnna J. Higgins
Anna J. Higgins
AFAlex J. Flynn
Alex J. Flynn
AMAnaïs Marconnet
Anaïs Marconnet
LMLaura J. Musgrove
Laura J. Musgrove
VPVincent L. G. Postis
Vincent L. G. Postis
Stephen MuenchStephen Muench
Stephen Muench

24 February 2005 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ATA. A. Toye
A. A. Toye
JLJ. D. Lippiat
J. D. Lippiat
PPP. Proks
P. Proks
KSK. Shimomura
K. Shimomura
LBL. Bentley
L. Bentley
RCR. D. Cox
R. D. Cox

6 December 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PPPeter Proks
Peter Proks
JAJennifer F. Antcliff
Jennifer F. Antcliff
JLJon Lippiat
Jon Lippiat
AGAnna Gloyn
Anna Gloyn
AHAndrew T. Hattersley
Andrew T. Hattersley
FAFrances M. Ashcroft
Frances M. Ashcroft
Inwardly rectifying potassium channels (Kir channels) control cell membrane K + fluxes and electrical signaling in diverse cell types. Heterozygous mutations in the human Kir6.2 gene ( KCNJ11 ), the pore-forming subunit of the ATP-sensitive (K ATP ) channel, cause permanent neonatal diabetes mellitus (PNDM). For some mutations, PNDM is accompanied by marked developmental delay, muscle weakness, and epilepsy (severe disease). To determine the molecular basis of these different phenotypes, we expressed wild-type or mutant (R201C, Q52R, or V59G) Kir6.2/sulfonylurea receptor 1 channels in Xenopus oocytes. All mutations increased resting whole-cell K ATP currents by reducing channel inhibition by ATP, but, in the simulated heterozygous state, mutations causing PNDM alone (R201C) produced smaller K ATP currents and less change in ATP sensitivity than mutations associated with severe disease (Q52R and V59G). This finding suggests that increased K ATP currents hyperpolarize pancreatic beta cells and impair insulin secretion, whereas larger K ATP currents are required to influence extrapancreatic cell function. We found that mutations causing PNDM alone impair ATP sensitivity directly (at the binding site), whereas those associated with severe disease act indirectly by biasing the channel conformation toward the open state. The effect of the mutation on ATP sensitivity in the heterozygous state reflects the different contributions of a single subunit in the Kir6.2 tetramer to ATP inhibition and to the energy of the open state. Our results also show that mutations in the slide helix of Kir6.2 (V59G) influence the channel kinetics, providing evidence that this domain is involved in Kir channel gating, and suggest that the efficacy of sulfonylurea therapy in PNDM may vary with genotype.

27 June 2017 in eLife
Verified
Journal Article
Open access
CTChristian Tiede
Christian Tiede
RBRobert Bedford
Robert Bedford
SHSophie J Heseltine
Sophie J Heseltine
GSGina Smith
Gina Smith
IWImeshi Wijetunga
Imeshi Wijetunga
DTDarren Charles Tomlinson
Darren Charles Tomlinson
Molecular recognition reagents are key tools for understanding biological processes and are used universally by scientists to study protein expression, localisation and interactions. Antibodies remain the most widely used of such reagents and many show excellent performance, although some are poorly characterised or have stability or batch variability issues, supporting the use of alternative binding proteins as complementary reagents for many applications. Here we report on the use of Affimer proteins as research reagents. We selected 12 diverse molecular targets for Affimer selection to exemplify their use in common molecular and cellular applications including the (a) selection against various target molecules; (b) modulation of protein function in vitro and in vivo; (c) labelling of tumour antigens in mouse models; and (d) use in affinity fluorescence and super-resolution microscopy. This work shows that Affimer proteins, as is the case for other alternative binding scaffolds, represent complementary affinity reagents to antibodies for various molecular and cell biology applications.

27 August 2013 in Science Signaling
Verified
Journal Article
Open access
PDF file
XJXin Jin
Xin Jin
SSShihab Shah
Shihab Shah
YLYani Liu
Yani Liu
HZHuiran Zhang
Huiran Zhang
MLMeredith Lees
Meredith Lees
NGNikita Gamper
Nikita Gamper
We report that anoctamin 1 (ANO1; also known as TMEM16A) Ca2+-activated Cl− channels in small neurons from dorsal root ganglia are preferentially activated by particular pools of intracellular Ca2+. These ANO1 channels can be selectively activated by the G protein–coupled receptor (GPCR)–induced release of Ca2+ from intracellular stores but not by Ca2+ influx through voltage-gated Ca2+ channels. This ability to discriminate between Ca2+ pools was achieved by the tethering of ANO1-containing plasma membrane domains, which also contained GPCRs such as bradykinin receptor 2 and protease-activated receptor 2, to juxtamembrane regions of the endoplasmic reticulum. Interaction of the carboxyl terminus and the first intracellular loop of ANO1 with IP3R1 (inositol 1,4,5-trisphosphate receptor 1) contributed to the tethering. Disruption of membrane microdomains blocked the ANO1 and IP3R1 interaction and resulted in the loss of coupling between GPCR signaling and ANO1. The junctional signaling complex enabled ANO1-mediated excitation in response to specific Ca2+signals rather than to global changes in intracellular Ca2+.

1 April 2003 in The Journal of Membrane Biology
Verified
Journal Article
Closed access
PDF file
NDN. W. Davies
N. W. Davies
JLJ. D. Lippiat
J. D. Lippiat
NSN. B. Standen
N. B. Standen
IHI. D. Harrow
I. D. Harrow
SPS. C. Phillips
S. C. Phillips